Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced the U.S. commercial launch of TRAUMAGEL®, a revolutionary plant-based ...
Some results have been hidden because they may be inaccessible to you